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Abstract
Background: To investigate long-term refractive outcomes, wavefront aberrations and quality of life after small
incision lenticule extraction (SMILE) for moderate to high myopia.
Methods: A total of 26 patients (47 eyes) with preoperative mean spherical equivalent (SE) of -6.30 ± 1.47 diopters (D)
who underwent SMILE were recruited. The measurements included uncorrected distance visual acuity (UDVA),
corrected distance visual acuity (CDVA), manifest refraction, wavefront aberrations, and quality of life.
Results: At 4 years postoperatively, UDVA was better than or equal to 20/20 in 92 % of eyes. The efficacy index
was 1.07 ± 0.16. 89 % of eyes were within ± 0.5 D of the intended refractive target. No eye lost any Snellen lines.
The safety index was 1.16 ± 0.14. No significant changes of SE occurred among postoperative follow-ups at
months 1, 3, 6 and years 1, 2, 4 (P > 0.05, Scheffe test). Higher-order aberrations, coma, spherical aberration and
higher-order astigmatism increased postoperatively, and no significant changes of aberrations were detected
among the 1-month, 6-month or 4-year follow-ups postoperatively (37 eyes). Compared to the spectacles
group, the surgery group showed a significantly higher total score on quality of life (45.71 ± 2.61 vs 39.96 ± 3.56,
P < 0.001).
Conclusions: SMILE provides a predictable and stable correction of moderate to high myopia as documented by
long-term follow-up.
Keywords: Small incision lenticule extraction (SMILE), Aberrations, Quality of life, Quality of Life Impact of Refractive
Correction (QIRC) questionnaire
Abbreviations: ANOVA, Analysis of variance; CDVA, Corrected distance visual acuity; D, Diopters; HOAs, Higher-order
aberrations; IQR, Interquartile range; LASIK, Laser in situ keratomileusis; PRK, Photorefractive keratectomy; QIRC, Quality
of life impact of refractive correction; RMS, Root mean square; SE, Spherical equivalent; SMILE, Small incision lenticule
extraction; SPSS, Statistical package for social sciences; UDVA, Uncorrected distance visual acuity
Background
Small incision lenticule extraction (SMILE) was first intro-
duced by Shah and Sekundo in 2011 [1, 2]. Compared to
laser in situ keratomileusis (LASIK), SMILE is a minimally
invasive and flap-less procedure. Promising clinical results
have been reported [3–14]. Only a few articles on the
long-term refractive outcomes after SMILE have been
reported [13, 15]. Scientific evidence documenting SMILE
over long-term follow-up is necessary to gain more
support and wider acceptance of the procedure [16]. The
aim of this study is to investigate four-year visual quality
(refractive outcomes and aberrations) and quality of life
outcomes after the SMILE procedure.
Methods
Subjects
Patients who underwent SMILE at the Refractive Surgery
Center of the Department of Ophthalmology, Eye and
ENT Hospital of Fudan University between January, 2011
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and May, 2012 were enrolled in the prospective study.
Inclusion criteria included age over 18 years, sphere
of -3.00 − -9.00 diopters (D) with astigmatism up to
-2.00 D, corrected distance visual acuity (CDVA) of
20/20 or better, stable refraction for 2 years, and no
use of any kind of contact lenses within the previous
2 weeks. Patients with systemic diseases, a history of
ocular surgery or trauma, or a history of ocular dis-
ease other than myopia or astigmatism were excluded.
Among these myopia patients, those who received
SMILE for both eyes were recruited in the quality-of-
life study. Patients over 39 years of age were excluded
as requisition of the Quality of Life Impact of Refract-
ive Correction (QIRC) questionnaire [17].A group of
individuals who wore spectacles full-time were enrolled as
a control. Inclusion criteria included age 18–39 years,
CDVA of 20/20 or better, sphere of -3.00 – -9.00 D with
astigmatism up to -2.00 D, stable refraction for 2 years,
use of spectacles for more than 4 years, and no other oph-
thalmic problems.
This study followed the tenets of the Declaration of
Helsinki and was approved by the ethics committee
of the Eye and ENT Hospital of Fudan University.
Informed written consent was obtained from all
participants.
Procedures
The same surgeon (XTZ) performed all the SMILE
procedures. The VisuMax femtosecond laser system
(Carl Zeiss Meditec, Jena, Germany) was used with a
repetition rate of 500 kHz and pulse energy of 130
nJ. The lenticule diameter was set at 6.5–6.7 mm and
the stromal cap was completed at a 100-μm depth
with a diameter of 7.5 mm. A 90-degree single side
cut with a length of 2.0–4.0 mm was created during
the procedure. After surgery, topical levofloxacin,
0.1 % fluorometholone solution, and non-preserved
artificial tears (carboxymethylcellulose sodium eye
drops; Allergan, Inc., Irvine, CA) were used.
Measurements
The outcome measures included uncorrected distance
visual acuity (UDVA), CDVA, manifest refraction, and
wavefront aberrations. Routine examinations, like slit-
lamp examination, rotating Scheimpflug camera imaging
(Pentacam, Oculus GmbH), were also preformed.
Postoperative time points included 1, 3, 6 months and
1, 2, 4 years postoperatively.
Wavefront aberrations were measured with a Hartmann–
Shack WASCA aberrometer (Carl Zeiss Meditec AG) with
a 6.0 mm pupil using sixth order Zernike polynomials. The
Table 1 Refractive outcomes during the follow-up period
Variables Preoperative 6 Months postoperative 4 Years postoperative P (Preop to 4 years postop) P (6 Months to 4 years postop)
LogMAR UDVA
Mean ± SD -0.05 ± 0.06 -0.04 ± 0.06 - 0.094
Medium(IQR) - -0.08(-0.08 to 0) -0.08(-0.08 to 0)
LogMAR CDVA
Mean -0.01 ± 0.03 -0.08 ± 0.06 -0.08 ± 0.06 <0.001 0.570
Medium(IQR) 0(0 to 0) -0.08(-0.08 to -0.08) -0.08(-0.08 to -0.08)
Sphere (D)
Mean ± SD -5.94 ± 1.45 0.14 ± 0.35 0.05 ± 0.41 <0.001 0.278
Range -8.50 to -3.25 -0.50 to 1.25 -1.00 to 1.25
Cylinder (D)
Mean ± SD -0.73 ± 0.49 -0.29 ± 0.27 -0.28 ± 0.29 <0.001 0.747
Medium(IQR) -0.50(-1.00 to 0) -0.25(-0.50 to 0) -0.25(-0.50 to 0)
SE
Mean ± SD -6.30 ± 1.47 -0.01 ± 0.33 -0.09 ± 0.39 <0.001 0.929
Range -8.75 to -3.50 -0.75 to 0.88 -1.00 to 0.88
The efficacy index
Mean ± SD - 1.11 ± 0.17 1.07 ± 0.16 - 0.275
Medium(IQR) 1.0(1.0 to 1.2) 1.0(1.0 to 1.2)
The safety index
Mean ± SD - 1.17 ± 0.15 1.16 ± 0.14 - 0.622
Medium(IQR) - 1.2(1.0 to 1.2) 1.2(1.0 to 1.2)
Preop preoperative, Postop postoperative, UDVA uncorrected distance visual acuity, IQR interquartile range, CDVA corrected distance visual acuity, D diopters, SE
spherical equivalent
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root mean square (RMS) of higher-order aberrations
(HOAs), spherical aberration, coma, higher-order astigma-
tism, trefoil and tetrafoil was calculated. Only measure-
ments in eyes with a pupil of 6.0 mm or larger were
included. Thus, the aberration measurements of thirty-
seven eyes for 1, 6 months and 4 years postoperatively were
collected.
The Chinese version of the QIRC questionnaire was
completed by Xu Congyi et al. [18] and showed favor-
able repeatability and validity. The QIRC questionnaire
Fig. 1 Refractive outcomes at 4 years postoperatively for 47 eyes with moderate to high myopia treated with SMILE. UDVA = uncorrected
distance visual acuity; CDVA = corrected distance visual acuity; D = diopters; Postop = postoperative; Preop = preoperative
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was used to assess the quality of life of the spectacles
group and the surgery group at the last follow-up.
Data analysis
All statistical analysis was performed using the Statistical
Package for Social Sciences (SPSS, Version 20) (IBM,
Armonk, NY, USA). The Kolmogorov–Smirnov test was
used to test for normality. Non-normally distributed
data were described as the mean, medium, and inter-
quartile range (IQR). One-way analysis of variance
(ANOVA) was used for the analysis of changes during
the time course, with Tukey test and Scheffe test for
multiple comparisons. When variables could not meet
the condition of ANOVA, the Wilcoxon signed-rank test
was used for paired data and the Mann-Whitney U test
was used for unpaired data. For proportions, Fisher’s
exact test was used. For all tests, a P < 0.05 was defined
as statistically significant.
Results
The preoperative mean age of the patients was 29.02 ±
7.23 years (range: 19–44 years) and mean spherical
equivalent (SE) was -6.30 ± 1.47 D (range: -3.50 – -8.75
D). The follow-up was 46.43 ± 2.33 months (range: 43–
58 months). None of the 47 eyes showed signs of
ectasia.
Refractive outcomes
Refractive outcomes pre-operatively and at postopera-
tive follow-ups at 6 months and 4 years are summarized
in Table 1 and Fig. 1. At the 4-year follow-up, UDVA
was better than or equal to 20/20 in 92 % of eyes and
20/16 in 53 %. The efficacy index was 1.07 ± 0.16. 89 %
of eyes were within ± 0.5 D of the intended refractive
target. No significant changes of SE occurred among
postoperative follow-ups at months 1, 3, 6 and years 1,
2, 4 (P > 0.05, Scheffe test). No eye lost any Snellen
lines and 9 % showed an increase of 2 lines. The safety
index was 1.16 ± 0.14.
Wavefront aberrations
Aberrations outcomes are summarized in Table 2.
HOAs, coma, and higher-order astigmatism increased
since 1 month postoperatively (Tukey test, P < 0.01).
Moreover, significant differences of spherical aberration
were found between preoperative values and values at
6 months, 4 years postoperatively (Tukey test, P < 0.05).
Among these aberrations, postoperative coma showed
the greatest increase after the surgery (Fig. 2). No signifi-
cant differences of HOAs, spherical aberration, coma,
higher-order astigmatism, trefoil and tetrafoil were de-
tected among the 1-month, 6-month or 4-year follow-
ups postoperatively (Tukey test, P > 0.05).
Quality of life evaluation
No significant difference in characteristics was found
between the surgery group and the spectacle group
(Table 3). There are 19 subjects in the surgery group
and 54 in the spectacle group, respectively. Compared
to the spectacles group, the surgery group showed a
significantly higher score in total score (45.71 ± 2.61
vs 39.96 ± 3.56, P < 0.001), the visual function, 4 of 5
convenience issues, both of the economic concerns,
and 1 of 7 well-being measurements (Table 4). There were
no significant differences between responses regarding
Table 2 Time course of aberrations after SMILE
Variables Preoperative 1 Month postoperative 6 Months postoperative 4 Years postoperative P
HOAs (μm) 0.31 ± 0.12 0.48 ± 0.16 0.53 ± 0.17 0.51 ± 0.11 <0.001
Spherical aberration (μm) 0.07 ± 0.15 0.15 ± 0.13 0.17 ± 0.14 0.18 ± 0.14 0.003
Coma (μm) 0.18 ± 0.13 0.36 ± 0.23 0.40 ± 0.23 0.40 ± 0.15 <0.001
Higher-order astigmatism (μm) 0.05 ± 0.03 0.09 ± 0.06 0.09 ± 0.05 0.10 ± 0.06 0.001
Trefoil (μm) 0.14 ± 0.08 0.16 ± 0.08 0.16 ± 0.08 0.16 ± 0.09 0.693
Tetrafoil (μm) 0.06 ± 0.03 0.08 ± 0.05 0.08 ± 0.04 0.08 ± 0.06 0.294
HOAs higher-order aberrations
Fig. 2 Changes of aberrations between time points after the SMILE
procedure. RMS = root mean square; HOAs = higher-order aberrations;
1 m-Pre = aberrations at 1 month minus preoperative aberrations;
3 m-Pre = aberrations at 3 months minus preoperative aberrations;
4y-Pre = aberrations at 4 years minus preoperative aberrations
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symptoms, 1 of 5 convenience concerns, any of 4 health
concerns, or 6 of 7 well-being measurements.
Discussion
SMILE has proven to be an effective, predictable and
safe procedure since Shah and Sekundo first introduced
it five years ago [3–12]. In this study, we report the
long-term observation of visual quality (refractive out-
comes and aberrations) and quality of life outcomes in
SMILE patients up to 58 months.
In this study, UDVA was better than or equal to 20/20
in 92 % of eyes and 20/16 in 53 %. No eye lost any line
of CDVA and 9 % showed an increase of 2 lines. The
efficacy and safety index were 1.07 ± 0.16 and 1.16 ±
0.14, respectively. Pedersen et al. showed 72 % eyes with
20/20 or better UDVA in 57 eyes of high myopia tar-
geted for emmetropia at 3 years after SMILE procedure
[15]. The discrepancy of UDVA results might due to the
different study subjects. Pedersen et al. showed the
refractive outcomes of patients with high myopia (92 %
of eyes more than -6.00D), while in this study, we stud-
ied the outcomes after SMILE for moderate to high my-
opia (59 % of eyes more than -6.00D). Kim et al. [3]
observed that at 12 months postoperatively, 93.1 % of
the eyes in the mild- to moderate-myopia group and
76.8 % of eyes in high myopia group had UDVA of 20/
20 or better (P < 0.05). Blum et al. showed the efficacy
index and safety index of the worldwide first 41 eyes
treated using SMILE at the 5-year follow-up was 0.9 and
1.2, respectively [13]. They performed SMILE with the
old type VisuMax at a repetition rate of 200 kHz with a
typical pulse energy <300 nJ, while we used the new type
VisuMax at a repetition rate of 500 kHz. A 500 kHz
VisuMax caused less tissue damage and resulted in bet-
ter outcomes. These results indicate the favorable effi-
cacy and safety of the SMILE procedure.
Considering long-term predictability and stability,
89 % of eyes were within 0.5 D and 100 % were within
1.0 D of the intended refractive target. In the study by
Pedersen IB et al., these values were 78 % and 90 %
respectively [15]. Blum et al. observed that 48.2 % of
eyes were within 0.5 D and 78.6 % were within 1.0 D
[13]. In our study, no significant changes in SE occurred
between postoperative follow-ups, although SE was
decreased from -0.01 ± 0.33 D at 6 months to -0.09 ±
0.39 D at four years after SMILE. No significant changes
of SE occurred were also reported by Pedersen et al. and
Blum et al. [13, 15]. These results demonstrate the pre-
dictability and stability of refractive outcomes after
SMILE with 4 years of follow up. In terms of other
refractive surgeries, several refractive results after LASIK
[19–21] and photorefractive keratectomy (PRK) [22]
showed a significant decline in SE over about ten years
after the surgery, especially for high corrections and
young patients. Therefore, it is necessary to investigate
the stability of SMILE in the long term.
HOAs play an important role in retinal image quality.
Similar to previous studies [1, 2, 8, 23], total HOAs,
coma, spherical aberration and higher-order astigmatism
increased postoperatively. Among these aberrations,
postoperative coma was most affected and remained
stable at all follow-up time points. The induced coma
might be associated with decentration and special efforts
should be made to minimize induced coma clinically
[24]. In addition, no significant changes of aberrations
were detected among the 1-month, 6-month, or 4-year
follow-ups postoperatively. However, this is in contrast
to a previous study using the Pentacam to analyze the
anterior, posterior and total corneal aberrations, in
which HOAs and spherical aberrations significantly de-
creased from 3 months to 3 years after SMILE [15]. In
this study, we used the Hartmann–Shack WASCA aber-
rometer which measures the whole-eye wavefront aber-
rations. Different measurements might result in the
different outcomes and the long-term changes of aberra-
tions on SMILE still need further discussion.
Quality of life metrics assesses the changes in physical,
functional, mental and social health in individuals. The
comparison of quality of life between common treat-
ments to myopia is helpful to evaluate the benefits of
the refractive surgery. The QIRC questionnaire targets
patients with refractive correction by spectacles, contact
lenses and refractive surgery, and is rigorously developed
using both conventional techniques and Rasch analysis
Table 3 Characteristics of the surgery and spectacles groups
Characteristics Surgery group Spectacles group P
Sample Size (n) 19 54 -
Sex (M/F) 6/13 24/30 0.241
Age 31.16 ± 5.39 30.04 ± 4.76 0.521
Myopia level (the worse eye, SE: -3.00 to -6.00D/<-6.00D) 6/13 22/32 0.336
Are you satisfied with your vision? (satisfied/unsatisfied) 19/0 51/3 0.399
How would you characterize your health? (good/excellent) 10/9 28/26 0.583
CDVA for the worse eye≥ 20/20 19/0 54/0 -
D diopters, SE spherical equivalent, CDVA corrected distance visual acuity
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Table 4 Differences in QIRC questionnaire items between surgery and spectacles groups
Variables Surgery group Spectacles group P
Mean SD Medium IQR Mean SD Medium IQR
1. Total score 45.71 2.61 45.36 43.73 to 47.51 39.96 3.56 39.42 37.11 to 41.65 <0.001
2. How much difficulty do you have driving in glare
conditions?
52.27 7.98 45.06 45.06 to 60.51 38.54 11.16 29.61 29.61 to 45.06 <0.001
3. During the past month, how often have you experienced
your eyes feeling tired or strained?
46.41 8.27 49.66 34.21 to 49.66 45.08 9.31 49.66 34.21 to 49.66 0.524
4. How much trouble is not being able to use off-the-shelf
(non prescription) sunglasses?
47.77 11.87 56.71 41.26 to 56.71 34.97 9.73 41.26 25.81 to 41.26 <0.001
5. How much trouble is having to think about your
spectacles or contact lenses or your eyes after refractive
surgery before doing things; eg, traveling, sport, going
swimming?
58.93 5.79 61.37 61.37 to 61.37 41.91 12.44 45.92 30.47 to 45.92 <0.001
6. How much trouble is not being able to see when you
wake up; eg, to go to the bathroom, look after a baby,
see alarm clock?
56.88 5.79 59.32 59.32 to 59.32 44.44 9.94 43.87 43.87 to 43.87 <0.001
7. How much trouble is not being able to see when you are
on the beach or swimming in the sea or pool, because
you do these activities without spectacles or contact
lenses?
57.42 11.87 63.92 48.48 to 63.92 36.66 7.93 33.03 33.03 to 33.03 <0.001
8. How much trouble is your spectacles or contact lenses
when you wear them when using a gym/ doing keep-fit
classes/circuit training, etc?
32.40 11.93 24.27 24.27 to 39.72 29.21 8.51 24.27 24.27 to 39.72 0.351
9. How concerned are you about the initial and ongoing
cost to buy your current spectacles/ contact lenses/
refractive surgery?
58.92 7.66 64.61 49.16 to 64.61 49.16 12.73 49.16 33.71 to 64.61 0.004
10. How concerned are you about the cost of unscheduled
maintenance of your spectacles/ contact lenses/
refractive surgery; eg, breakage, loss, new eye problems?
47.61 13.87 45.18 29.73 to 60.62 38.88 12.19 29.73 29.73 to 45.18 0.015
11. How concerned are you about having to increasingly
rely on your spectacles or contact lenses since you
started to wear them?
42.69 13.00 34.56 34.56 to 50.01 47.72 13.22 50.01 34.56 to 65.46 0.128
12. How concerned are you about your vision not being as
good as it could be?
38.31 8.68 34.24 34.24 to 32.24 38.82 9.31 34.24 34.24 to 34.24 0.889
How concerned are you about medical complications from
your choice of optical correction (spectacles, contact lenses
and/or refractive surgery)?
34.28 10.57 28.59 28.59 to 44.04 38.89 11.23 44.04 28.59 to 44.04 0.084
13. How concerned are you about eye protection from
ultraviolet (UV) radiation?
39.79 8.68 35.72 35.72 to 35.72 43.73 11.52 35.72 35.72 to 51.17 0.182
14. During the past month, how much of the time have you
felt that you have looked your best?
39.75 12.36 45.52 28.25 to 45.52 38.11 12.97 28.25 28.25 to 45.52 0.536
15. During the past month, how much of the time have you
felt that you think others see you the way you would
like them to (eg, intelligent, sophisticated, successful,
cool, etc)?
47.17 5.45 48.99 48.99 to 48.99 43.01 11.01 48.99 31.72 to 48.99 0.079
16. During the past month, how much of the time have you
felt complimented/flattered?
51.51 11.34 54.55 37.28 to 54.55 48.50 12.01 54.55 37.28 to 54.55 0.304
17. During the past month, how much of the time have you
felt confident?
44.87 9.63 42.67 42.67 to 57.94 39.10 11.98 42.67 25.40 to 42.67 0.063
18. During the past month, how much of the time have you
felt happy?
46.04 7.75 39.61 39.61 to 54.88 38.60 10.51 39.61 39.61 to 39.61 0.008
19. During the past month, how much of the time have you
felt able to do the things you want to do?
30.65 6.71 31.66 31.66 to 31.66 27.59 15.93 31.66 14.39 to 31.66 0.078
20. During the past month, how much of the time have you
felt eager to try new things?
42.61 9.10 41.22 41.22 to 41.22 38.76 17.08 41.22 23.95 to 41.22 0.067
QIRC Quality of Life Impact of Refractive Correction, IQR interquartile range
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[17]. The QIRC questionnaire has been used to measure
differences between patients with correction by LASIK
and other two modes of refractive correction [25, 26]. In
this study, long-term quality of life outcomes on SMILE
patients were studied. The total score of the QIRC ques-
tionnaire was significantly higher in the surgery group
than the spectacles group. Compared to patients with re-
fractive correction by spectacles, patients who underwent
SMILE showed better refractive error-related quality of life
and SMILE brings both economic benefits and conveni-
ence to individuals with moderate to high myopia.
A major weakness of this article is the relatively small
sample size. It may limit the precision of the results.
Further randomized and multi-centered studies with a
larger sample size were of clinical significance.
Conclusions
In conclusion, SMILE provides a predictable and stable cor-
rection of moderate to high myopia in the long-term
follow-up. Patients who underwent SMILE showed better
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